Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis. Yiu ZZN. Br J Dermatol 2025 Sep 23:ljaf316. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yiu ZZN. Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis. Br J Dermatol 2025 Sep 23:ljaf316. doi: 10.1093.
PMID: 40985307